Comments
Loading...
CVS Health Analyst Ratings and Price Targets | NYSE:CVS | Benzinga
CVS Health Corp has a consensus price target of $81.26 based on the ratings of 28 analysts. The high is $143 issued by Jefferies on February 9, 2023. The low is $58 issued by RBC Capital on November 15, 2024. The 3 most-recent analyst ratings were released by Baird, Truist Securities, and Mizuho on April 15, 2025, April 11, 2025, and April 9, 2025, respectively. With an average price target of $76.33 between Baird, Truist Securities, and Mizuho, there's an implied 15.08% upside for CVS Health Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Baird
Truist Securities
Mizuho
Piper Sandler
JP Morgan
1calculated from analyst ratings
Analyst Ratings for CVS Health
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/15/2025 | Buy Now | 7.04% | Baird | Michael Ha48% | $51 → $71 | Maintains | Neutral | Get Alert |
| 04/11/2025 | Buy Now | 23.62% | Truist Securities | David Macdonald65% | $76 → $82 | Maintains | Buy | Get Alert |
| 04/09/2025 | Buy Now | 14.58% | Mizuho | Ann Hynes85% | $70 → $76 | Maintains | Outperform | Get Alert |
| 03/21/2025 | Buy Now | 11.56% | Piper Sandler | Jessica Tassan38% | $72 → $74 | Maintains | Overweight | Get Alert |
| 02/18/2025 | Buy Now | 22.12% | JP Morgan | Lisa Gill58% | $80 → $81 | Maintains | Overweight | Get Alert |
| 02/13/2025 | Buy Now | 10.06% | Wells Fargo | Stephen Baxter55% | $68 → $73 | Maintains | Overweight | Get Alert |
| 02/13/2025 | Buy Now | 14.58% | Truist Securities | David Macdonald65% | $60 → $76 | Maintains | Buy | Get Alert |
| 02/13/2025 | Buy Now | 10.06% | Barclays | Andrew Mok54% | $71 → $73 | Maintains | Overweight | Get Alert |
| 02/13/2025 | Buy Now | 13.07% | Leerink Partners | Michael Cherny78% | $55 → $75 | Upgrade | Market Perform → Outperform | Get Alert |
| 01/27/2025 | Buy Now | -2.01% | Evercore ISI Group | Elizabeth Anderson44% | $60 → $65 | Maintains | Outperform | Get Alert |
| 01/06/2025 | Buy Now | -9.54% | Truist Securities | David Macdonald65% | $67 → $60 | Maintains | Buy | Get Alert |
| 12/03/2024 | Buy Now | -0.5% | Deutsche Bank | George Hill62% | $66 → $66 | Upgrade | Hold → Buy | Get Alert |
| 11/25/2024 | Buy Now | 20.61% | TD Cowen | Charles Ryhee51% | $73 → $80 | Maintains | Buy | Get Alert |
| 11/25/2024 | Buy Now | -3.51% | Piper Sandler | Jessica Tassan38% | $72 → $64 | Maintains | Overweight | Get Alert |
| 11/20/2024 | Buy Now | 1.01% | Truist Securities | David Macdonald65% | $76 → $67 | Reiterates | Buy → Buy | Get Alert |
| 11/18/2024 | Buy Now | -0.5% | Wells Fargo | Stephen Baxter55% | $60 → $66 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 11/15/2024 | Buy Now | -12.56% | RBC Capital | Ben Hendrix59% | $68 → $58 | Maintains | Outperform | Get Alert |
| 11/07/2024 | Buy Now | -6.53% | UBS | Kevin Caliendo70% | $60 → $62 | Maintains | Neutral | Get Alert |
| 11/07/2024 | Buy Now | 7.04% | Barclays | Andrew Mok54% | $75 → $71 | Maintains | Overweight | Get Alert |
| 11/04/2024 | Buy Now | -9.54% | Wells Fargo | Stephen Baxter55% | $61 → $60 | Maintains | Equal-Weight | Get Alert |
| 10/24/2024 | Buy Now | -0.5% | Mizuho | Ann Hynes85% | $73 → $66 | Maintains | Outperform | Get Alert |
| 10/23/2024 | Buy Now | 13.07% | Barclays | Andrew Mok54% | $82 → $75 | Maintains | Overweight | Get Alert |
| 10/11/2024 | Buy Now | 14.58% | Truist Securities | David Macdonald65% | $66 → $76 | Maintains | Buy | Get Alert |
| 10/10/2024 | Buy Now | 23.62% | Barclays | Andrew Mok54% | $63 → $82 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 10/08/2024 | Buy Now | 13.07% | Evercore ISI Group | Elizabeth Anderson44% | $62 → $75 | Maintains | Outperform | Get Alert |
| 10/04/2024 | Buy Now | 28.15% | TD Cowen | Charles Ryhee51% | $59 → $85 | Upgrade | Hold → Buy | Get Alert |
| 10/01/2024 | Buy Now | -6.53% | Cantor Fitzgerald | Sarah James50% | $62 → $62 | Reiterates | Neutral → Neutral | Get Alert |
| 09/16/2024 | Buy Now | -6.53% | Cantor Fitzgerald | Sarah James50% | $62 → $62 | Reiterates | Neutral → Neutral | Get Alert |
| 09/10/2024 | Buy Now | -6.53% | Cantor Fitzgerald | Sarah James50% | $62 → $62 | Reiterates | Neutral → Neutral | Get Alert |
| 09/04/2024 | Buy Now | 2.52% | RBC Capital | Ben Hendrix59% | $68 → $68 | Reiterates | Outperform → Outperform | Get Alert |
| 08/19/2024 | Buy Now | -6.53% | Cantor Fitzgerald | Sarah James50% | $62 → $62 | Reiterates | Neutral → Neutral | Get Alert |
| 08/12/2024 | Buy Now | -8.04% | Wells Fargo | Stephen Baxter55% | $60 → $61 | Maintains | Equal-Weight | Get Alert |
| 08/09/2024 | Buy Now | -5.02% | Deutsche Bank | George Hill62% | $64 → $63 | Maintains | Hold | Get Alert |
| 08/08/2024 | Buy Now | -5.02% | Barclays | Andrew Mok54% | $65 → $63 | Maintains | Equal-Weight | Get Alert |
| 08/08/2024 | Buy Now | -6.53% | Cantor Fitzgerald | Sarah James50% | $58 → $62 | Maintains | Neutral | Get Alert |
| 08/08/2024 | Buy Now | -6.53% | Evercore ISI Group | Elizabeth Anderson44% | $65 → $62 | Maintains | Outperform | Get Alert |
| 07/23/2024 | Buy Now | -12.56% | Cantor Fitzgerald | Sarah James50% | $58 → $58 | Reiterates | Neutral → Neutral | Get Alert |
| 06/12/2024 | Buy Now | -12.56% | Cantor Fitzgerald | Sarah James50% | $58 → $58 | Reiterates | Neutral → Neutral | Get Alert |
| 05/30/2024 | Buy Now | 29.65% | JP Morgan | Lisa Gill58% | $101 → $86 | Maintains | Overweight | Get Alert |
| 05/30/2024 | Buy Now | -8.04% | Baird | Michael Ha48% | → $61 | Initiates | → Neutral | Get Alert |
| 05/08/2024 | Buy Now | 20.61% | Argus Research | Chris Graja68% | $100 → $80 | Maintains | Buy | Get Alert |
| 05/07/2024 | Buy Now | -9.54% | Wells Fargo | Stephen Baxter55% | $76 → $60 | Maintains | Equal-Weight | Get Alert |
| 05/07/2024 | Buy Now | -11.05% | TD Cowen | Charles Ryhee51% | $99 → $59 | Downgrade | Buy → Hold | Get Alert |
| 05/02/2024 | Buy Now | 16.09% | B of A Securities | Michael Cherny78% | $95 → $77 | Maintains | Buy | Get Alert |
| 05/02/2024 | Buy Now | 11.56% | Goldman Sachs | Nathan Rice57% | $85 → $74 | Maintains | Buy | Get Alert |
| 05/02/2024 | Buy Now | -5.02% | Barclays | Andrew Mok54% | $78 → $63 | Maintains | Equal-Weight | Get Alert |
| 05/02/2024 | Buy Now | -9.54% | UBS | Kevin Caliendo70% | $85 → $60 | Downgrade | Buy → Neutral | Get Alert |
| 05/02/2024 | Buy Now | -0.5% | Truist Securities | David Macdonald65% | $90 → $66 | Reiterates | Buy → Buy | Get Alert |
| 05/02/2024 | Buy Now | 8.55% | Mizuho | Ann Hynes85% | $86 → $72 | Maintains | Buy | Get Alert |
| 05/01/2024 | Buy Now | -9.54% | Leerink Partners | Michael Cherny78% | → $60 | Downgrade | Outperform → Market Perform | Get Alert |
| 05/01/2024 | Buy Now | -12.56% | Cantor Fitzgerald | Sarah James50% | $87 → $58 | Downgrade | Overweight → Neutral | Get Alert |
| 04/10/2024 | Buy Now | 31.16% | Cantor Fitzgerald | Sarah James50% | $87 → $87 | Reiterates | Overweight → Overweight | Get Alert |
| 04/08/2024 | Buy Now | 14.58% | Wells Fargo | Stephen Baxter55% | $83 → $76 | Maintains | Equal-Weight | Get Alert |
| 04/04/2024 | Buy Now | 31.16% | Cantor Fitzgerald | Sarah James50% | $87 → $87 | Reiterates | Overweight → Overweight | Get Alert |
| 03/15/2024 | Buy Now | 41.72% | Piper Sandler | Jessica Tassan38% | $93 → $94 | Maintains | Overweight | Get Alert |
| 03/06/2024 | Buy Now | 17.59% | Barclays | Andrew Mok54% | → $78 | Initiates | → Equal-Weight | Get Alert |
| 02/26/2024 | Buy Now | 32.67% | Leerink Partners | Michael Cherny78% | → $88 | Initiates | → Outperform | Get Alert |
| 02/08/2024 | Buy Now | 31.16% | Cantor Fitzgerald | Sarah James50% | $87 → $87 | Reiterates | Overweight → Overweight | Get Alert |
| 02/08/2024 | Buy Now | 26.64% | RBC Capital | Ben Hendrix59% | $86 → $84 | Maintains | Outperform | Get Alert |
| 12/22/2023 | Buy Now | 41.72% | HSBC | Daniela Bretthauer54% | → $94 | Initiates | → Buy | Get Alert |
| 12/11/2023 | Buy Now | 49.25% | TD Cowen | Charles Ryhee51% | $102 → $99 | Maintains | Outperform | Get Alert |
| 11/21/2023 | Buy Now | 31.16% | Cantor Fitzgerald | Sarah James50% | → $87 | Reiterates | Overweight → Overweight | Get Alert |
| 11/02/2023 | Buy Now | 29.65% | Mizuho | Ann Hynes85% | $88 → $86 | Maintains | Buy | Get Alert |
| 11/02/2023 | Buy Now | 29.65% | RBC Capital | Ben Hendrix59% | $91 → $86 | Maintains | Outperform | Get Alert |
| 11/02/2023 | Buy Now | 50.76% | Morgan Stanley | Erin Wright76% | $110 → $100 | Maintains | Overweight | Get Alert |
| 09/19/2023 | Buy Now | 25.13% | Evercore ISI Group | Elizabeth Anderson44% | $81 → $83 | Upgrade | In-Line → Outperform | Get Alert |
| 09/14/2023 | Buy Now | 31.16% | Cantor Fitzgerald | Sarah James50% | → $87 | Reiterates | Overweight → Overweight | Get Alert |
| 09/12/2023 | Buy Now | 20.61% | Wolfe Research | Justin Lake33% | → $80 | Upgrade | Peer Perform → Outperform | Get Alert |
| 09/01/2023 | Buy Now | 23.62% | Piper Sandler | Jessica Tassan38% | $85 → $82 | Maintains | Overweight | Get Alert |
| 08/18/2023 | Buy Now | 37.19% | RBC Capital | Ben Hendrix59% | → $91 | Reiterates | Outperform → Outperform | Get Alert |
| 08/18/2023 | Buy Now | — | Edward Jones | Ashtyn Evans1% | — | Downgrade | Buy → Hold | Get Alert |
| 08/04/2023 | Buy Now | 28.15% | Raymond James | John Ransom76% | $90 → $85 | Maintains | Outperform | Get Alert |
| 08/03/2023 | Buy Now | 47.75% | Truist Securities | David Macdonald65% | $103 → $98 | Maintains | Buy | Get Alert |
| 08/03/2023 | Buy Now | 65.84% | Morgan Stanley | Erin Wright76% | $120 → $110 | Maintains | Overweight | Get Alert |
| 08/03/2023 | Buy Now | 37.19% | RBC Capital | Ben Hendrix59% | $102 → $91 | Maintains | Outperform | Get Alert |
| 08/03/2023 | Buy Now | 29.65% | Barclays | Steve Valiquette54% | $89 → $86 | Maintains | Overweight | Get Alert |
| 07/12/2023 | Buy Now | 34.18% | Barclays | Steve Valiquette54% | $90 → $89 | Maintains | Overweight | Get Alert |
| 07/11/2023 | Buy Now | 32.67% | Mizuho | Ann Hynes85% | $120 → $88 | Maintains | Buy | Get Alert |
| 07/07/2023 | Buy Now | 59.81% | JP Morgan | Lisa Gill58% | $114 → $106 | Maintains | Overweight | Get Alert |
| 06/20/2023 | Buy Now | 55.28% | Truist Securities | David Macdonald65% | $109 → $103 | Maintains | Buy | Get Alert |
| 05/30/2023 | Buy Now | 71.87% | JP Morgan | Lisa Gill58% | $125 → $114 | Maintains | Overweight | Get Alert |
| 05/26/2023 | Buy Now | 28.15% | Piper Sandler | Jessica Tassan38% | → $85 | Initiates | → Overweight | Get Alert |
| 05/09/2023 | Buy Now | 53.78% | RBC Capital | Ben Hendrix59% | → $102 | Reiterates | → Outperform | Get Alert |
| 05/08/2023 | Buy Now | 14.58% | Wells Fargo | Stephen Baxter55% | $95 → $76 | Maintains | Equal-Weight | Get Alert |
| 05/08/2023 | Buy Now | 44.73% | Credit Suisse | A.J. Rice69% | $125 → $96 | Maintains | Outperform | Get Alert |
| 05/08/2023 | Buy Now | 35.69% | Raymond James | John Ransom76% | $110 → $90 | Maintains | Outperform | Get Alert |
| 05/05/2023 | Buy Now | 32.67% | Goldman Sachs | Nathan Rice57% | $100 → $88 | Maintains | Buy | Get Alert |
| 05/04/2023 | Buy Now | 32.67% | Goldman Sachs | Nathan Rich43% | $100 → $88 | Maintains | Buy | Get Alert |
| 05/04/2023 | Buy Now | 35.69% | Barclays | Steve Valiquette54% | $100 → $90 | Maintains | Overweight | Get Alert |
| 05/02/2023 | Buy Now | 41.72% | UBS | Kevin Caliendo70% | $102 → $94 | Maintains | Buy | Get Alert |
| 05/02/2023 | Buy Now | 40.21% | Bernstein | Lance Wilkes62% | $107 → $93 | Maintains | Market Perform | Get Alert |
| 04/21/2023 | Buy Now | 31.16% | Cantor Fitzgerald | Sarah James50% | → $87 | Initiates | → Overweight | Get Alert |
| 04/18/2023 | Buy Now | 67.35% | TD Cowen | Charles Ryhee51% | $118 → $111 | Maintains | Outperform | Get Alert |
| 03/31/2023 | Buy Now | 56.79% | B of A Securities | Michael Cherny78% | $111 → $104 | Maintains | Buy | Get Alert |
| 03/30/2023 | Buy Now | 50.76% | Barclays | Steven Valiquette58% | $110 → $100 | Maintains | Overweight | Get Alert |
| 02/09/2023 | Buy Now | 115.59% | Jefferies | Brian Tanquilut45% | $130 → $143 | Maintains | Buy | Get Alert |
| 02/09/2023 | Buy Now | 73.38% | RBC Capital | Ben Hendrix59% | → $115 | Reiterates | → Outperform | Get Alert |
| 02/09/2023 | Buy Now | 65.84% | Raymond James | John Ransom76% | $115 → $110 | Maintains | Outperform | Get Alert |
| 02/09/2023 | Buy Now | 65.84% | Barclays | Steve Valiquette54% | $118 → $110 | Maintains | Overweight | Get Alert |
| 01/13/2023 | Buy Now | 80.91% | Morgan Stanley | Erin Wright76% | $119 → $120 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for CVS Health (CVS) stock?
The latest price target for CVS Health (NYSE:CVS) was reported by Baird on April 15, 2025. The analyst firm set a price target for $71.00 expecting CVS to rise to within 12 months (a possible 7.04% upside). 51 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CVS Health (CVS)?
The latest analyst rating for CVS Health (NYSE:CVS) was provided by Baird, and CVS Health maintained their neutral rating.
When was the last upgrade for CVS Health (CVS)?
The last upgrade for CVS Health Corp happened on February 13, 2025 when Leerink Partners raised their price target to $75. Leerink Partners previously had a market perform for CVS Health Corp.
When was the last downgrade for CVS Health (CVS)?
The last downgrade for CVS Health Corp happened on May 7, 2024 when TD Cowen changed their price target from $99 to $59 for CVS Health Corp.
When is the next analyst rating going to be posted or updated for CVS Health (CVS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CVS Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CVS Health was filed on April 15, 2025 so you should expect the next rating to be made available sometime around April 15, 2026.
Is the Analyst Rating CVS Health (CVS) correct?
While ratings are subjective and will change, the latest CVS Health (CVS) rating was a maintained with a price target of $51.00 to $71.00. The current price CVS Health (CVS) is trading at is $66.33, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
